Loading...
Loading...
Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.
Idenix Pharmaceuticals
IDIX has a PEG ratio of 0.11. Idenix's trailing-twelve-month revenue is $33.54 million.
Exelixis
EXEL has a PEG ratio of 0.17. Exelixis had $351.97 million in total cash for the latest quarter.
InterMune
ITMN has a PEG ratio of 0.30. InterMune is expected to post revenue of $20.91 million for the December quarter.
Lexicon Pharmaceuticals
LXRX has a PEG ratio 0.62. Lexicon's trailing-twelve-month revenue is $1.16 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in